Company / Revenue
RIGEL PHARMACEUTICALS INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$294.3M
FY2025
5-year range
$116.9M / $294.3M
FY2021-FY2025
Trend
+64.1%
vs FY2024
Sector context
#77 of 155
Health Care
What the data says
At $294M, RIGEL PHARMACEUTICALS INC's revenue ranks #77 of 155 in the Health Care sector. Revenue has fluctuated over the past 10 years, ranging from $4M in FY2017 to $294M in FY2025.
Based on SEC 10-K filings.
$294M in FY2025 with a 5-year CAGR of +22.1%.
Improved from $117M to $294M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +34.8%
- 5-Year CAGR
- +22.1%
- 10-Year CAGR
- -
Sector benchmark
#77 of 155 in Health CareTop 50% of 155This company $294.3M Sector average $4.5B
▼
-93.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.1%, indicating consistent growth.
- In FY2025, revenue increased 64.1% year-over-year.
- Ranks #77 out of 155 companies in the Health Care sector.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $294.3M | +64.1% |
| FY2024 | $179.3M | +53.4% |
| FY2023 | $116.9M | -2.8% |
| FY2022 | $120.2M | -19.4% |
| FY2021 | $149.2M | +37.4% |
| FY2020 | $108.6M | +83.2% |
| FY2019 | $59.3M | +190.9% |
| FY2018 | $20.4M | +354.6% |
| FY2017 | $4.5M | -78.0% |
| FY2016 | $20.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026